Status:
NOT_YET_RECRUITING
Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis
Lead Sponsor:
Zagazig University
Conditions:
Onychomycosis
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconaz...
Detailed Description
The sample size will be calculated by a statistician based upon the rate of onychomycosis cases attending at the outpatient clinical. 3 equal groups of patients will be included. inclusion criteria in...
Eligibility Criteria
Inclusion
- patients with onychomycosis
Exclusion
- pregnant and lactating females patients on statin therapy or photosensitizing drugs patients with liver disease, heart disease and diabetes milletus.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06485505
Start Date
July 1 2024
End Date
December 1 2024
Last Update
July 3 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.